Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ELV Elevance Health Inc

435,68

4,78 (1,11%)

Nach Börsenschluss

Zuletzt aktualisiert: 01:10:31

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

10/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Carmen Zamores as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kendrick Charles Morgan JR

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Elevance Health (NYSE:ELV)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more Elevance Health Charts.

Elevance Health (NYSE:ELV)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more Elevance Health Charts.

News Elevance Health Inc

Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
Montag 31 März 2025 (1 Woche vor) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 11 März 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 10 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 10 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Mittwoch 5 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Weitere Elevance Health Inc News-Artikel

Lululemon Athletica

CRISPR Therapeutics

Takeda Pharmaceutical

Citigroup DBN MB

Ameriprise Financial

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen